ONCOLOGY INSTITUTE INC/THE (TOI)

US68236X1000 - Common Stock

0.2151  -0.02 (-8.55%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
203M
8.27%
252.5M
24.38%
324.239M
28.41%
418.81M
29.17%
EBITDA
YoY % growth
-42.56M
-747.81%
-67.59M
-58.81%
-54.278M
19.70%
-18.079M
66.69%
EBIT
YoY % growth
-45.9M
-459.76%
-72M
-56.86%
-60.151M
16.46%
-23.907M
60.26%
Operating Margin
-22.61%-28.51%-18.55%-5.71%
EPS
YoY % growth
N/AN/A-0.69
-36.63%
-0.42
38.52%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.18
5.26%
-0.06-0.12-197.03%
Q2 2024
Q2Q % growth
-0.17
10.53%
-0.10-0.07-68.32%
Q1 2024
Q2Q % growth
-0.22
-120.00%
-0.12-0.10-81.52%
Q4 2023
Q2Q % growth
-0.21
16.00%
-0.11-0.10-89.02%
Q3 2023
Q2Q % growth
-0.19
24.00%
-0.13-0.06-44.71%
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
99.9M
21.78%
108.62M-8.72M-8.03%
Q2 2024
Q2Q % growth
98.578M
22.88%
104.34M-5.762M-5.52%
Q1 2024
Q2Q % growth
94.666M
24.25%
96.117M-1.451M-1.51%
Q4 2023
Q2Q % growth
85.788M
20.12%
82.862M2.926M3.53%
Q3 2023
Q2Q % growth
82.035M
26.25%
75.411M6.624M8.78%
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% 0%
Revenue0% 0% 0% 0%